Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Transitional Cell × Vitamins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 2 Vomiting 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pain, Postoperative 1 Nausea 1 Motor Activity 1 Malnutrition 1 Carcinoma, Transitional Cell 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

pembrolizumab 22 Gemcitabine 18 Nivolumab 16 Cisplatin 15 atezolizumab 13 Carboplatin 10 vinflunine 7 avelumab 7 Paclitaxel 6 Ipilimumab 6 Docetaxel 5 enfortumab vedotin 4 cabazitaxel 4 Taxes 3 Rogaratinib 3 Pemetrexed 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3 Injections 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 pemigatinib 2 lenvatinib 2 cabozantinib 2 bempegaldesleukin 2 XRP6258 2 Vitamin D 2 Standard of Care 2 Ramucirumab 2 Everolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490437 2014-09-25

PECULIAR

Asan Medical Center

Phase 2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡